A detailed history of Continuum Advisory, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Continuum Advisory, LLC holds 28,148 shares of PFE stock, worth $719,744. This represents 0.1% of its overall portfolio holdings.

Number of Shares
28,148
Previous 25,185 11.76%
Holding current value
$719,744
Previous $704,000 15.63%
% of portfolio
0.1%
Previous 0.1%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$27.7 - $31.39 $82,075 - $93,008
2,963 Added 11.76%
28,148 $814,000
Q2 2024

Jul 19, 2024

BUY
$25.26 - $29.6 $9,093 - $10,656
360 Added 1.45%
25,185 $704,000
Q1 2024

May 10, 2024

SELL
$25.89 - $29.73 $357,722 - $410,779
-13,817 Reduced 35.76%
24,825 $688,000
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $761,193 - $988,706
-29,131 Reduced 42.98%
38,642 $1.11 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $184,549 - $215,720
5,751 Added 9.27%
67,773 $2.25 Million
Q2 2023

Dec 13, 2023

SELL
$36.12 - $41.79 $687,471 - $795,389
-19,033 Reduced 23.48%
62,022 $2.27 Million
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $687,471 - $795,389
-19,033 Reduced 23.48%
62,022 $2.27 Million
Q1 2023

Dec 13, 2023

BUY
$39.39 - $51.28 $281,914 - $367,010
7,157 Added 9.68%
81,055 $3.31 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $281,914 - $367,010
7,157 Added 9.68%
81,055 $3.31 Million
Q4 2022

Dec 13, 2023

BUY
$41.75 - $54.5 $17,284 - $22,563
414 Added 0.56%
73,898 $3.79 Million
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $17,284 - $22,563
414 Added 0.56%
73,898 $3.79 Million
Q3 2022

Dec 13, 2023

BUY
$43.76 - $53.42 $463,768 - $566,145
10,598 Added 16.85%
73,484 $3.22 Million
Q3 2022

Nov 08, 2022

BUY
$43.76 - $53.42 $463,768 - $566,145
10,598 Added 16.85%
73,484 $2.06 Million
Q2 2022

Dec 13, 2023

BUY
$46.53 - $55.17 $175,604 - $208,211
3,774 Added 6.38%
62,886 $3.3 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $175,604 - $208,211
3,774 Added 6.38%
62,886 $1.91 Million
Q1 2022

Dec 13, 2023

BUY
$45.75 - $56.69 $844,590 - $1.05 Million
18,461 Added 45.41%
59,112 $3.06 Million
Q1 2022

May 17, 2022

BUY
$45.75 - $56.69 $844,590 - $1.05 Million
18,461 Added 45.41%
59,112 $1.6 Million
Q4 2021

Dec 13, 2023

BUY
$41.32 - $61.25 $64,500 - $95,611
1,561 Added 3.99%
40,651 $2.4 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $64,500 - $95,611
1,561 Added 3.99%
40,651 $833,000
Q3 2021

Dec 13, 2023

BUY
$39.25 - $50.42 $1.07 Million - $1.38 Million
27,351 Added 232.99%
39,090 $1.68 Million
Q3 2021

Nov 08, 2021

BUY
$39.25 - $50.42 $1.07 Million - $1.38 Million
27,351 Added 232.99%
39,090 $547,000
Q2 2021

Dec 13, 2023

SELL
$35.91 - $40.68 $2.01 Million - $2.28 Million
-56,034 Reduced 82.68%
11,739 $459,000
Q2 2021

Aug 17, 2021

BUY
$35.91 - $40.68 $146,620 - $166,096
4,083 Added 53.33%
11,739 $460,000
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $39,417 - $44,455
1,177 Added 18.17%
7,656 $288,000
Q4 2020

May 17, 2021

BUY
$33.47 - $42.56 $216,852 - $275,746
6,479 New
6,479 $238,000
Q2 2020

May 18, 2021

SELL
$30.12 - $36.54 $217,737 - $264,147
-7,229 Closed
0 $0
Q1 2020

May 18, 2021

BUY
$27.03 - $38.62 $195,399 - $279,183
7,229 New
7,229 $230,000
Q1 2019

May 18, 2021

SELL
$37.5 - $41.2 $183,975 - $202,127
-4,906 Closed
0 $0
Q4 2018

May 18, 2021

SELL
$38.47 - $43.86 $118,987 - $135,658
-3,093 Reduced 38.67%
4,906 $214,000
Q3 2018

May 18, 2021

SELL
$34.47 - $41.81 $6,514 - $7,902
-189 Reduced 2.31%
7,999 $354,000
Q2 2018

May 18, 2021

SELL
$32.98 - $35.16 $75,326 - $80,305
-2,284 Reduced 21.81%
8,188 $297,000
Q1 2018

May 18, 2021

SELL
$31.91 - $37.02 $253,014 - $293,531
-7,929 Reduced 43.09%
10,472 $372,000
Q4 2017

May 18, 2021

BUY
$33.26 - $35.29 $215,990 - $229,173
6,494 Added 54.54%
18,401 $666,000
Q3 2017

May 18, 2021

SELL
$31.0 - $34.15 $15,407 - $16,972
-497 Reduced 4.01%
11,907 $425,000
Q2 2017

May 18, 2021

BUY
N/A
1,036 Added 9.11%
12,404 $417,000
Q1 2017

May 18, 2021

BUY
N/A
11,368
11,368 $389,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.